Abbott Laboratories 

ABT:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
37.76 0.28   0.75%1.48%5,429,8987.2M

Market data is delayed by at least 20 minutes.
Market is closed. As of 03:59 PM ET 5/24/2013
 
 
 

Latest News Headlines for Abbott Laboratories

Abbott to Present at Deutsche Bank 38th Annual Health Care Conference
5 days 14 hours 55 minutes ago - PR Newswire via Dow Jones News
ABBOTT PARK, Ill., May 22, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Deutsche Bank 38(th) Annual Health Care Conference on Wednesday, May 29, 2013. Thomas C. Freyman, executive vice president, finance and chief financial officer, and Scott White, senior vice president, international nutrition, will present at 1:10 p.m. Central time.
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
6 days 15 hours 24 minutes ago - PR Newswire via Dow Jones News
- XIENCE Xpedition(TM) 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents - Has the Potential to Reduce Overall Procedural Costs - Very Long Lesions Most Often Seen in Patients with Diabetes
View more recent headlines
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
February 15, 2013
This report contains detailed information about the company's business finances and management.
10-Q
May 8, 2013
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
37.17
Previous Close
37.48
Day High
37.84
Day Low
37.11
52wk High/Date
72.47 / 10/16/2012
52wk Low/Date
31.64 / 1/2/2013
% off 52wk High
-47.90%
% off 52wk Low
19.34%
Beta (5 Yr)
0.4
Market Capitalization
58.9B
Shares Outstanding
1.6B
Volatility Avg
16.68
EPS(TTM)
0.49
P/E Ratio
77.2x
Dividend Announcement
2/15/2013
Dividend Yield
1.48%
Ex-Date
4/11/2013
Date of Record
4/15/2013
Payable
0.14 - QRTR
Payable Date
5/15/2013
Last Trade as of 5/24/2013 4:04 PM ET
 
 
 

ABT Abbott Laboratories vs. Peers

Peers 
ABT
Abbott Laboratories
20.49%
Johnson & Johnson
23.85%
Pfizer Inc.
15.79%
ABT
Abbott Laboratories
1.48%
Johnson & Johnson
3.04%
Pfizer Inc.
3.31%
ABT
Abbott Laboratories
0.75%
Johnson & Johnson
-0.45%
Pfizer Inc.
-0.24%
Compare these stocks